☰

Kien Pham, Ph.D. - Publications

Affiliations: 
2013 Pharmacology and Therapeutics University of Florida, Gainesville, Gainesville, FL, United States 
Area:
Pharmacology, Oncology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Pham K, DeFina S, Wang H. E-Cigarettes Promote Macrophage-Tumor Cells Crosstalk: Focus on Breast Carcinoma Progression and Lung Metastasis. Exploratory Research and Hypothesis in Medicine. 6: 60-66. PMID 35419501 DOI: 10.14218/erhm.2021.00002  0.348
2020 Pham K, Huynh D, Le L, Delitto D, Yang L, Huang J, Kang Y, Steinberg MB, Li J, Zhang L, Liu D, Tang MS, Liu C, Wang H. E-cigarette promotes breast carcinoma progression and lung metastasis: Macrophage-tumor cells crosstalk and the role of CCL5 and VCAM-1. Cancer Letters. PMID 32829009 DOI: 10.1016/J.Canlet.2020.08.010  0.327
2020 Brown M, Zhang W, Yan D, Kenath R, Le L, Wang H, Delitto D, Ostrov D, Robertson K, Liu C, Pham K. The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC. Plos One. 15: e0226917. PMID 31929540 DOI: 10.1371/Journal.Pone.0226917  0.55
2020 Wang X, Wu Q, Pham K, Luna A, Danilenko M, Liu C, Studzinski GP. Abstract 1811: Sorafenib-mediated apoptotic and autophagic cell death is increased by carnosic acid and a vitamin D2 analog in hepatocellular carcinoma (HCC) Cancer Research. 80: 1811-1811. DOI: 10.1158/1538-7445.Am2020-1811  0.313
2019 Wu Q, Wang X, Pham K, Luna A, Studzinski GP, Liu C. Enhancement of sorafenib-mediated death of Hepatocellular carcinoma cells by Carnosic acid and Vitamin D2 analog combination. The Journal of Steroid Biochemistry and Molecular Biology. 105524. PMID 31704246 DOI: 10.1016/J.Jsbmb.2019.105524  0.325
2019 Sivaram N, McLaughlin PA, Han HV, Petrenko O, Jiang YP, Ballou LM, Pham K, Liu C, van der Velden AW, Lin RZ. Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer. The Journal of Clinical Investigation. 130. PMID 31112530 DOI: 10.1172/Jci123540  0.509
2019 Chan N, Riedlinger G, Lu S, Pham K, Kirstein L, Eladoumikdachi F, George M, Potdevin L, Kowzun M, Desai S, Tang D, Omene C, Wong S, Rodriguez-Rust L, Kumar S, et al. Abstract P1-15-14: Neoadjuvant liposomal doxorubicin and carboplatin is effective and tolerable for the treatment of triple negative breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P1-15-14  0.36
2019 Sivaram N, McLaughlin P, Jiang Y, Ballou L, Pham K, Liu C, Velden Avd, Lin R. Abstract 522: PI3K/Akt signaling in tumor cells promotes immune evasion by limiting infiltration, recognition and killing by T cells Cancer Research. 79: 522-522. DOI: 10.1158/1538-7445.Am2019-522  0.512
2018 Paratala BS, Chung JH, Williams CB, Yilmazel B, Petrosky W, Williams K, Schrock AB, Gay LM, Lee E, Dolfi SC, Pham K, Lin S, Yao M, Kulkarni A, DiClemente F, et al. RET rearrangements are actionable alterations in breast cancer. Nature Communications. 9: 4821. PMID 30446652 DOI: 10.1038/S41467-018-07341-4  0.331
2017 Wu Q, Pi L, Le Trinh T, Zuo C, Xia M, Jiao Y, Hou Z, Jo S, Puszyk W, Pham K, Nelson DR, Robertson K, Ostrov D, Rameshwar P, Xia CQ, et al. A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28865999 DOI: 10.1016/J.Ymthe.2017.08.005  0.414
2016 Delitto D, Delitto AE, DiVita BB, Pham K, Han S, Hartlage ER, Newby BN, Gerber MH, Behrns KE, Moldawer LL, Thomas RM, George T, Brusko T, Mathews CE, Liu C, et al. Human pancreatic cancer cells induce a MyD88-dependent stromal response to promote a tumor-tolerant immune microenvironment. Cancer Research. PMID 27864347 DOI: 10.1158/0008-5472.Can-16-1765  0.44
2016 Pham K, Delitto D, Knowlton AE, Hartlage ER, Madhavan R, Gonzalo DH, Thomas RM, Behrns KE, George TJ, Hughes SJ, Wallet SM, Liu C, Trevino JG. Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserved Heterogeneity in Culture. The American Journal of Pathology. PMID 27102771 DOI: 10.1016/J.Ajpath.2016.02.009  0.448
2015 Delitto D, Perez C, Han S, Gonzalo DH, Pham K, Knowlton AE, Graves CL, Behrns KE, Moldawer LL, Thomas RM, Liu C, George TJ, Trevino JG, Wallet SM, Hughes SJ. Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer. Cancer Immunology, Immunotherapy : Cii. PMID 26423423 DOI: 10.1007/S00262-015-1760-Y  0.48
2015 Delitto D, Pham K, Vlada AC, Sarosi GA, Thomas RM, Behrns KE, Liu C, Hughes SJ, Wallet SM, Trevino JG. Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements. The American Journal of Pathology. 185: 1297-303. PMID 25770474 DOI: 10.1016/J.Ajpath.2015.01.016  0.495
2015 Pham K, Luo D, Siemann DW, Law BK, Reynolds BA, Hothi P, Foltz G, Harrison JK. VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a TGFβR signaling-dependent manner. Cancer Letters. 360: 60-7. PMID 25676691 DOI: 10.1016/J.Canlet.2015.02.005  0.666
2015 Delitto D, Pham K, Vlada AC, Sarosi GA, Thomas RM, Behrns KE, Liu C, Hughes SJ, Wallet SM, Trevino JG. Abstract 1466: Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through the incorporation of murine stromal elements Cancer Research. 75: 1466-1466. DOI: 10.1158/1538-7445.Am2015-1466  0.498
2014 Pham K, Luo D, Siemann D, Law B, Reynolds B, Hothi P, Foltz G, Harrison J. AI-24 * VEGFR INHIBITORS ENHANCE PROGRESSION OF GLIOBLASTOMA BY UPREGULATING CXCR4 IN A TGF R SIGNALING-DEPENDENT MANNER Neuro-Oncology. 16: v6-v6. DOI: 10.1093/Neuonc/Nou238.24  0.662
2013 Liu C, Pham K, Luo D, Reynolds BA, Hothi P, Foltz G, Harrison JK. Expression and functional heterogeneity of chemokine receptors CXCR4 and CXCR7 in primary patient-derived glioblastoma cells. Plos One. 8: e59750. PMID 23555768 DOI: 10.1371/Journal.Pone.0059750  0.676
2012 Jahn SC, Law ME, Corsino PE, Parker NN, Pham K, Davis BJ, Lu J, Law BK. An in vivo model of epithelial to mesenchymal transition reveals a mitogenic switch. Cancer Letters. 326: 183-90. PMID 22906417 DOI: 10.1016/J.Canlet.2012.08.013  0.425
2012 Pham K, Luo D, Liu C, Harrison JK. CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5. Journal of Neuroimmunology. 246: 10-7. PMID 22425022 DOI: 10.1016/J.Jneuroim.2012.02.009  0.637
2012 Pham K, Liu C, Luo D, Reynolds BA, Harrison JK. Abstract 5194: Heterogenous expression of chemokine receptors in primary patient-derived GBM lines; association of CXCR3, CXCR4, and CXCR7 with a slow cycling sub-population Cancer Research. 72: 5194-5194. DOI: 10.1158/1538-7445.Am2012-5194  0.667
Show low-probability matches.